135 related articles for article (PubMed ID: 8401635)
1. Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1): recommended approach. Pathologists of the French Association of Urology Cancer Committee.
World J Urol; 1993; 11(3):161-4. PubMed ID: 8401635
[TBL] [Abstract][Full Text] [Related]
2. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
Paner GP; Montironi R; Amin MB
Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
[TBL] [Abstract][Full Text] [Related]
4. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course.
Takashi M; Sakata T; Murase T; Hamajima N; Miyake K
Nagoya J Med Sci; 1991 Mar; 53(1-4):1-8. PubMed ID: 1805133
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and substaging of pT1 bladder cancer].
Cheng L; Huang WB; Zheng SQ; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
[No Abstract] [Full Text] [Related]
6. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
Lawless M; Gulati R; Tretiakova M
Histopathology; 2017 Sep; 71(3):406-414. PubMed ID: 28470753
[TBL] [Abstract][Full Text] [Related]
7. pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging.
Raspollini MR; Montironi R; Mazzucchelli R; Cimadamore A; Cheng L; Lopez-Beltran A
Virchows Arch; 2020 Jul; 477(1):3-16. PubMed ID: 32296929
[TBL] [Abstract][Full Text] [Related]
8. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828
[TBL] [Abstract][Full Text] [Related]
10. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.
Hermann GG; Horn T; Steven K
J Urol; 1998 Jan; 159(1):91-4. PubMed ID: 9400444
[TBL] [Abstract][Full Text] [Related]
11. Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.
Chang BS; Kim HL; Yang XJ; Steinberg GD
Urology; 2001 Jun; 57(6):1063-6; discussion 1066-7. PubMed ID: 11377305
[TBL] [Abstract][Full Text] [Related]
12. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.
Bochner BH; Nichols PW; Skinner DG
Urology; 1995 Mar; 45(3):528-31. PubMed ID: 7879346
[TBL] [Abstract][Full Text] [Related]
13. Some pitfalls in pathological staging of invasive urothelial carcinoma.
MacLennan GT; Taylor JM
J Urol; 2004 Oct; 172(4 Pt 1):1464. PubMed ID: 15371871
[No Abstract] [Full Text] [Related]
14. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
[TBL] [Abstract][Full Text] [Related]
15. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
16. [So-called "superficial" bladder tumors. Which classification in 2003? Part 1: Papillary tumors].
Billerey C; Sibony M
Ann Pathol; 2003 Feb; 23(1):21-33. PubMed ID: 12743497
[TBL] [Abstract][Full Text] [Related]
17. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
18. Muscularis mucosa of urinary bladder. Importance for staging and treatment.
Ro JY; Ayala AG; el-Naggar A
Am J Surg Pathol; 1987 Sep; 11(9):668-73. PubMed ID: 3631381
[TBL] [Abstract][Full Text] [Related]
19. Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder.
Abou Farha KM; Janknegt RA; Kester AD; Arends JW
Urol Int; 1993; 50(3):133-40. PubMed ID: 7682019
[TBL] [Abstract][Full Text] [Related]
20. Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders.
Robertson AJ; Beck JS; Burnett RA; Howatson SR; Lee FD; Lessells AM; McLaren KM; Moss SM; Simpson JG; Smith GD
J Clin Pathol; 1990 Jan; 43(1):17-21. PubMed ID: 2312745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
